Walkey CJ - Search Results

1

Maf1 and Repression of RNA Polymerase III-Mediated Transcription Drive Adipocyte Differentiation.

Chen CY, Lanz RB, Walkey CJ, Chang WH, Lu W, Johnson DL. Chen CY, et al. Among authors: walkey cj. Cell Rep. 2018 Aug 14;24(7):1852-1864. doi: 10.1016/j.celrep.2018.07.046. Cell Rep. 2018. PMID: 30110641 Free PMC article.

2

Elevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer.

Johnson SAS, Lin JJ, Walkey CJ, Leathers MP, Coarfa C, Johnson DL. Johnson SAS, et al. Among authors: walkey cj. Oncotarget. 2017 Jul 25;8(30):48832-48845. doi: 10.18632/oncotarget.16384. Oncotarget. 2017. PMID: 28415573 Free PMC article.

3

The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis.

Wang X, Rusin A, Walkey CJ, Lin JJ, Johnson DL. Wang X, et al. Among authors: walkey cj. J Biol Chem. 2019 Dec 13;294(50):19255-19268. doi: 10.1074/jbc.RA119.008849. Epub 2019 Oct 23. J Biol Chem. 2019. PMID: 31645432 Free PMC article.

4

Susceptibility of Rat Steatotic Liver to Ischemia-Reperfusion Is Treatable With Liver-Selective Matrix Metalloproteinase Inhibition.

Wang X, Walkey CJ, Maretti-Mira AC, Wang L, Johnson DL, DeLeve LD. Wang X, et al. Among authors: walkey cj. Hepatology. 2020 Nov;72(5):1771-1785. doi: 10.1002/hep.31179. Epub 2020 Oct 22. Hepatology. 2020. PMID: 32060938 Free PMC article.

5

MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass.

Phillips E, Ahmad N, Sun L, Iben J, Walkey CJ, Rusin A, Yuen T, Rosen CJ, Willis IM, Zaidi M, Johnson DL. Phillips E, et al. Among authors: walkey cj. Elife. 2022 May 25;11:e74740. doi: 10.7554/eLife.74740. Elife. 2022. PMID: 35611941 Free PMC article.

6

Overexpression of rat liver CTP:phosphocholine cytidylyltransferase accelerates phosphatidylcholine synthesis and degradation.

Walkey CJ, Kalmar GB, Cornell RB. Walkey CJ, et al. J Biol Chem. 1994 Feb 25;269(8):5742-9. J Biol Chem. 1994. PMID: 8119913 Free article.

7

Recent advances in genome editing for cardiovascular disease.

Doerfler AM, Walkey CJ, Lagor WR. Doerfler AM, et al. Among authors: walkey cj. Curr Opin Cardiol. 2020 May;35(3):242-248. doi: 10.1097/HCO.0000000000000723. Curr Opin Cardiol. 2020. PMID: 32073405 Free PMC article. Review.

8

The unique acyl chain specificity of biliary phosphatidylcholines in mice is independent of their biosynthetic origin in the liver.

Agellon LB, Walkey CJ, Vance DE, Kuipers F, Verkade HJ. Agellon LB, et al. Among authors: walkey cj. Hepatology. 1999 Sep;30(3):725-9. doi: 10.1002/hep.510300305. Hepatology. 1999. PMID: 10462379

9

A functional peroxisome proliferator-activated receptor-gamma ligand-binding domain is not required for adipogenesis.

Walkey CJ, Spiegelman BM. Walkey CJ, et al. J Biol Chem. 2008 Sep 5;283(36):24290-4. doi: 10.1074/jbc.C800139200. Epub 2008 Jul 11. J Biol Chem. 2008. PMID: 18622018 Free PMC article.

10

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.

Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM. Puigserver P, et al. Among authors: walkey cj. Nature. 2003 May 29;423(6939):550-5. doi: 10.1038/nature01667. Epub 2003 May 18. Nature. 2003. PMID: 12754525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters